- The anti-CCP test measures an antibody often linked to rheumatoid arthritis (RA).
- It is usually ordered along with other tests, such as rheumatoid factor, and with a clinical exam.
- Reference ranges and units vary by lab, so your own report's range and your clinician's interpretation are what count.
- A positive result raises the likelihood of RA but does not by itself confirm it; a negative result does not fully rule it out.
- Rheumatologists interpret the result together with symptoms, exam findings, imaging, and other labs.
- Do not self-diagnose or start any treatment based on one result; discuss next steps with your clinician.
The anti-CCP test (anti-cyclic citrullinated peptide antibody test, sometimes called anti-CCP or ACPA) is a blood test that looks for a specific antibody the immune system can produce in rheumatoid arthritis (RA). It is commonly used, along with other tests and a physical exam, to help evaluate joint pain and stiffness that might be due to inflammatory arthritis. This guide explains what the test measures, how results are generally read, and why interpretation belongs with a clinician, ideally a rheumatologist, rather than a lab printout alone.
What the test measures
In rheumatoid arthritis, the immune system can mistakenly target the body’s own tissues, and one group of antibodies it may make is directed against citrullinated proteins. The anti-CCP test detects these antibodies in the blood. They tend to be fairly specific to RA, meaning that when they are present, RA is more likely, though the result is still just one piece of the diagnostic picture. Anti-CCP is often measured alongside rheumatoid factor (RF), another antibody linked to RA, and with inflammation markers such as ESR or CRP.
Why a doctor might order it
- To help evaluate suspected rheumatoid arthritis in someone with joint pain, swelling, or morning stiffness.
- To add specificity when rheumatoid factor is positive, since RF can also appear in other conditions.
- To help with early assessment, because anti-CCP antibodies can sometimes be present early in the disease.
- To inform prognosis in some cases, as higher levels have been associated with more active joint disease in research.
The test is ordered as part of an evaluation, not as a stand-alone screen for the general public.
Typical ranges and units (they vary)
Anti-CCP results are usually reported as a number with a cutoff for “negative,” “positive,” or sometimes “weakly” versus “strongly” positive, often in units such as units per milliliter (U/mL). Laboratories use different assays and set their own cutoffs, so what counts as positive can differ from one lab to another. Because of this variation, you should not compare your result to a range you found online or to a friend’s result from a different lab. The result that matters is the one your clinician interprets against your symptoms, exam, imaging, and other tests.
| Result | General meaning (interpreted in context) |
|---|---|
| Positive anti-CCP | Raises the likelihood of RA; supports but does not alone confirm the diagnosis |
| Strongly positive | Further increases likelihood; may relate to more active disease in some studies |
| Negative anti-CCP | Makes RA less likely but does not fully rule it out (some people with RA test negative) |
| Positive with negative RF | Still meaningful; anti-CCP can be present when rheumatoid factor is not |
These are general patterns only, not a diagnosis. RA is diagnosed clinically, using classification criteria that combine several findings.
What positive or negative results may suggest
A positive anti-CCP increases the probability of rheumatoid arthritis and, because the antibody is relatively specific, it can help distinguish RA from other causes of joint pain. However, a positive result alone does not confirm RA, and antibodies can occasionally appear before clear symptoms. A negative anti-CCP lowers the likelihood but does not exclude RA, since a portion of people with RA are “seronegative.” This is why rheumatologists combine the antibody results with the number and pattern of affected joints, symptom duration, inflammation markers, and imaging. In people diagnosed with RA, treatment planning is individualized, and some research even explores how genetics may affect medication response through pharmacogenomic testing.
What to do with your result
The safest approach is to bring your result to the clinician who ordered it, ideally a rheumatologist if RA is being considered. Do not self-diagnose or start any treatment, including over-the-counter anti-inflammatories as a long-term plan, based on one antibody result. Early, well-managed RA care matters, so timely follow-up is worthwhile if symptoms persist. If you have been diagnosed and want to understand research options, you can read about clinical trials for rheumatoid arthritis, remembering that trials are research, not guaranteed treatment. For more careful, evidence-based context on testing, visit our evidence-first wellness guides.
Frequently asked questions
What is the anti-CCP test used for? It helps evaluate suspected rheumatoid arthritis, usually alongside rheumatoid factor, inflammation markers, a physical exam, and sometimes imaging.
Does a positive result mean I have rheumatoid arthritis? Not by itself. It raises the likelihood, but RA is diagnosed clinically using several findings together.
Can I have RA with a negative anti-CCP? Yes. Some people with RA test negative (seronegative), so a negative result does not fully rule it out.
What is a normal anti-CCP level? Cutoffs and units vary by laboratory and assay. Your own lab’s cutoff and your clinician’s interpretation are what count.
Is anti-CCP the same as rheumatoid factor? No. They are different antibodies. Anti-CCP is generally more specific to RA, and the two are often tested together.
Do I need to fast before the test? Usually no special preparation is needed, but follow the specific instructions from the lab or clinician who ordered it.
This article is for general education and is not medical advice. Supplements and therapies affect people differently and can interact with medications or conditions. Talk to your doctor, pharmacist, or a licensed clinician before making changes to your health routine.
Sources
- MedlinePlus — Anti-CCP Test and Rheumatoid Factor
- Mayo Clinic — Rheumatoid arthritis diagnosis and testing
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) — Rheumatoid arthritis
- American College of Rheumatology — Rheumatoid arthritis and laboratory tests